Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Neuroscience ; 281: 99-109, 2014 Dec 05.
Article in English | MEDLINE | ID: mdl-25267387

ABSTRACT

In certain forms of nerve injury and inflammation, noradrenaline augments pain via actions on up-regulated α1-adrenoceptors (α1-ARs). The aim of this study was to use immunohistochemistry to examine α1-AR expression on peripheral neurons, cutaneous blood vessels and keratinocytes after distal tibia fracture and cast immobilization, a model of complex regional pain syndrome type 1. We hypothesized that there would be increased α1-AR expression on neurons and keratinocytes in the injured limb in comparison to the contralateral unaffected limb after distal tibia fracture, in association with inflammatory changes and pain. α1-AR expression was increased on plantar keratinocytes, dermal blood vessels and peripheral nerve fibers at 16weeks after injury both in the fractured and contralateral uninjured limb. Similar changes were seen in controls whose limb had been immobilized in a cast for 4weeks but not fractured. Neurofilament 200 (NF200), a marker of myelinated neurons, and calcitonin gene-related peptide (CGRP), a neuropeptide involved in neuro-inflammatory signaling, decreased 4weeks after fracture and casting but then increased at the 16-week time point. As some of these changes were also detected in the contralateral hind limb, they probably were triggered by a systemic response to fracture and casting. Soon after the cast was removed, intraplantar injections of the α1-AR antagonist prazosin released local vasoconstrictor tone but had no effect on pain behaviors. However, systemic injection of prazosin inhibited behavioral signs of pain, suggesting that fracture and/or casting triggered an up-regulation of α1-ARs in central nociceptive pathways that augmented pain. Together, these findings indicate that α1-AR expression increases in the hind limbs after distal tibia fracture and cast immobilization. However, these peripheral increases do not contribute directly to residual pain.


Subject(s)
Adrenergic alpha-1 Receptor Antagonists/pharmacology , Blood Vessels/metabolism , Calcitonin Gene-Related Peptide/metabolism , Chronic Pain/metabolism , Keratinocytes/metabolism , Neurofilament Proteins/metabolism , Receptors, Adrenergic, alpha-1/metabolism , Sciatic Nerve/metabolism , Skin/blood supply , Tibial Fractures/metabolism , Tibial Nerve/metabolism , Animals , Behavior, Animal , Casts, Surgical , Chronic Pain/drug therapy , Disease Models, Animal , Male , Rats , Rats, Sprague-Dawley , Time Factors
2.
Neuroscience ; 175: 300-14, 2011 Feb 23.
Article in English | MEDLINE | ID: mdl-21182905

ABSTRACT

The purpose of this study was to determine whether α(1)-adrenoceptors are expressed on primary nociceptive afferents that innervate healthy skin. Skin and dorsal root ganglia were collected from adult male Wistar rats and assessed using fluorescence immunohistochemistry with antibodies directed against α(1)-adrenoceptors alone or in combination with specific labels including myelin basic protein and neurofilament 200 (markers of myelinated nerve fibres), protein gene product 9.5 (a pan-neuronal marker), tyrosine hydroxylase (sympathetic neurons), isolectin B(4) (IB(4): non-peptidergic sensory neurons), calcitonin gene related peptide (CGRP) and transient receptor potential vanilloid receptor 1 (TRPV1) (peptidergic sensory neurons). Double labelling in dorsal root ganglia confirmed the expression of α(1)-adrenoceptors within sub-populations of CGRP, IB(4) and TRPV1 immunoreactive neurons. Myelinated and unmyelinated sensory nerve fibres in the skin expressed α(1)-adrenoceptors whereas sympathetic nerve fibres did not. The expression of α(1)-adrenoceptors on C- and A-delta nociceptive afferent fibres provides a histochemical substrate for direct excitation of these fibres by adrenergic agonists. This may help to explain the mechanism of sensory-sympathetic coupling that sometimes develops on surviving primary nociceptive afferents in neuropathic pain states.


Subject(s)
Ganglia, Spinal/metabolism , Nociceptors/metabolism , Receptors, Adrenergic, alpha-1/biosynthesis , Sensory Receptor Cells/metabolism , Skin/innervation , TRPV Cation Channels/biosynthesis , Afferent Pathways/metabolism , Afferent Pathways/pathology , Animals , Ganglia, Spinal/cytology , Ganglia, Spinal/physiology , Male , Nociceptors/pathology , Nociceptors/physiology , Pain/metabolism , Pain/physiopathology , Rats , Rats, Wistar , Receptors, Adrenergic, alpha-1/physiology , Sensory Receptor Cells/cytology , Sensory Receptor Cells/physiology , Synaptic Transmission/physiology , TRPV Cation Channels/physiology
3.
Biochem Biophys Res Commun ; 276(2): 454-60, 2000 Sep 24.
Article in English | MEDLINE | ID: mdl-11027496

ABSTRACT

The desmosomal cadherins comprise the desmocollins and desmogleins and are involved in epithelial cell-cell adhesion. There are three desmocollins (DSC 1-3) and three desmogleins (DSG 1-3) that are expressed in a tissue- and development-specific manner. Desmosomal proteins have been implicated in a number of disorders characterized by loss of cell-cell adhesion and trauma-induced skin fragility. Therefore, the desmocollins are potential candidates for genodermatoses involving epithelial tissues. In order to screen the entire DSC1 and DSC3 genes, we have characterized their intron-exon organization. The DSC1 gene comprises 17 exons spanning approximately 33 kb on 18q12.1, and the DSC3 gene comprises 17 exons spanning approximately 49 kb on 18q12.1. We have also developed a comprehensive PCR-based mutation detection strategy for desmocollins 1, 2, and 3 using primers placed on flanking introns followed by direct sequencing of the PCR products.


Subject(s)
Cadherins/genetics , Desmosomes/genetics , Membrane Glycoproteins/genetics , Cloning, Molecular , DNA Mutational Analysis , DNA Primers , Desmocollins , Exons , Gene Amplification , Genome, Human , Humans , Introns
SELECTION OF CITATIONS
SEARCH DETAIL
...